Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Read the full announcement: #CordisGoBeyond #Cordis #InterventionalCardiology #LateBreakingClinicalData #SELUTIONSLR #DEB To view or add a comment, sign in Today we announced additional Week 12 results from the Phase 2b ANTHEM-UC study of icotrokinra, a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor, in adults with moderately to severely active ulcerative colitis (UC)
Under the Human Medicines Regulations 2012 , it is unlawful to sell or supply unlicensed prescription-only medicines (POMs) without appropriate authorisation
Analysts project blockbuster potential, with peak sales estimates reaching $2 billion to $3 billion
You will then be able to pick up your prescription directly at our clinic, ensuring you have the correct medication for your weight loss journey
